ストックスクリーナーアプリを入手
527.32
2.53%
13.09
前日終値:
$514.23
開ける：
$516.34
24時間の取引高:
925.28K
Relative Volume:
0.41
時価総額：
$195.94B
収益：
$44.56B
当期純損益:
$6.72B
株価収益率:
29.73
EPS:
17.7387
ネットキャッシュフロー:
$6.29B
1週間 パフォーマンス:
+7.71%
1か月 パフォーマンス:
+13.54%
6か月 パフォーマンス:
+0.27%
1年 パフォーマンス:
+17.34%
1日の値動き範囲:
$514.00
$530.00
1週間の範囲:
$490.25
$530.00
52週間の値動き範囲:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
527.25 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
199.05 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
583.69 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
121.20 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
333.00 | 31.41B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | DZ Bank | Buy |
| 2025-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-12-01 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-09-11 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 開始されました | William Blair | Outperform |
| 2025-07-24 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Barclays Adjusts Price Target on Thermo Fisher Scientific to $625 From $650, Maintains Overweight Rating - marketscreener.com
A Look At Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Volatility - Yahoo Finance
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities - BioSpace
Thermo Fisher Scientific Inc (TMO) Shares Surge 3.6% -- What GF Score of 88 Tells Investors - GuruFocus
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand R - PharmiWeb.com
Small Molecule Innovator API CDMO Market Outlook, 2026-2033Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry - Yahoo Finance UK
TD Cowen lowers Thermo Fisher stock price target on valuation reset - Investing.com
Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities - Contract Pharma
Thermo Fisher Scientific Inc. and HealthVerity Collaborate To Expand Real-World Data Capabilities - marketscreener.com
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $625 From $683, Maintains Buy Rating - marketscreener.com
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $610 From $650, Maintains Buy Rating - marketscreener.com
Thermo Fisher stock may benefit following collaboration with PRECISE - MSN
Thermo Fisher PRECISE SG100K Partnership Puts Valuation And Growth In Focus - Yahoo Finance
Wallace Advisory Group Reduces Stake in Thermo Fisher Scientific - National Today
Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance
Thermo Fisher Launches Automated Cell Therapy System - Technology Networks
Thermo Fisher expands global biobank leadership through collaboration with PRECISE-SG100K Singapore - BioSpectrum Asia
Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSN
The Market Is Selling Everything, but These 5 Stocks Aren’t Breaking Down - Investing.com
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE - Yahoo Finance
Flow Cytometry Market is experiencing boost at an infinite speed - openPR.com
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Thermo Fisher Shares Could See Gains After Teaming Up With PRECISE - Bitget
Thermo Fisher Scientific Expands Global Biobank Leadership - National Today
Thermo Fisher Scientific and Precision Health Research Singapore Enter Strategic Collaboration to Advance Precise-SG100K Study - marketscreener.com
Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PREC - PharmiWeb.com
Thermo Fisher, Singapore’s PRECISE Partner on Population-Scale Proteomics Biobank - Contract Pharma
Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study - BioPharma APAC
TMO Partners with Precision Health for Major Biobank Study - GuruFocus
Thermo Fisher Scientific Signs Strategic Deal With Precision Health Research, Singapore to Support PRECISE-SG100K Study - marketscreener.com
Thermo Fisher partners with Singapore biobank study By Investing.com - Investing.com India
Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort - Benzinga
Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics - Business Wire
Thermo Fisher Saladax TDM Deal Adds Dimension To Diagnostics Growth Story - Yahoo Finance
How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Its Cell Therapy And Biologics Platforms - Sahm
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc. (TMO) stock price, news, quote and history - Yahoo Finance Singapore
Biotechnology Reagents and Kits Market Set to Witness Rapid - openPR.com
[ARS] THERMO FISHER SCIENTIFIC INC. SEC Filing - Stock Titan
Thermo Fisher (NYSE: TMO) outlines 2025 performance, CEO retention grant and 2026 pay overhaul - Stock Titan
Thermo Fisher (TMO) Poised for Growth with Upcoming Catalysts - GuruFocus
Lobbying Update: $21,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
Thermo Fisher Introduces Gibco CTS Compleo Fill and Finish System - Contract Pharma
Electron Microscopes Market Is Going to Boom |• Thermo Fisher Scientific • JEOL Ltd. - openPR.com
Thermo Fisher Scientific Inc. $TMO Shares Sold by Rathbones Group PLC - MarketBeat
Biotech layoffs pick back up as 14 companies cut 745 jobs in Q1 - The Business Journals
JB Capital LLC Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
1.63%
大文字化:
|
ボリューム (24 時間):